Description: Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China.
Home Page: www.anpacbio.com
ANPC Technical Analysis
801 Bixing Street
Lishui,
323006
China
Phone:
86 57 8205 1666
Officers
| Name | Title |
|---|---|
| Dr. Chris Chang Yu | Co-Founder, Co-CEO & Co-Chairman |
| Mr. Haohan Xu | Co-CEO & Co-Chairperson |
| Dr. He Yu | Co-Founder & Chief Medical Officer |
| Ms. Xiaoyu Li | CFO & Director |
| Mr. Weidong Dai | China Pres |
| Dr. Sunil Pandit | U.S. Chief Exec. Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 5.6732 |
| Price-to-Sales TTM: | 0.412 |
| IPO Date: | 2020-01-30 |
| Fiscal Year End: | December |
| Full Time Employees: | 89 |